Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

Nurix Therapeutics, Inc.

CIK 1549595Updated Nov 17, 2026

Name history
Nurix, Inc. · through Sep 18, 2015

NRIX price & chart

Provider market data

Loading TradingView…

NASDAQ:NRIX on TradingView ↗

TradingView · Data may be delayed

About the company

Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and autoimmune diseases. Nurix’s wholly owned, clinical stage pipeline includes degraders of Bruton’s tyrosine kinase (BTK), a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene B (CBL-B), an E3 ligase that regulates activation of multiple immune cell types including T cells and NK cells. Nurix also is advancing multiple potentially first-in-class or best-in-class degraders and degrader antibody conjugates (DACs) in its preclinical pipeline. Nurix’s partnered drug discovery pipeline consists of a preclinical stage degrader of STAT6, SAR448272/NX-3911, in collaboration with Sanofi, a clinical stage degrader of IRAK4, GS6791, in collaboration with Gilead, as well as multiple additional programs under collaboration agreements with Gilead Sciences, Inc., Sanofi S.A. and Pfizer Inc., within which Nurix retains certain options for co-development, co-commercialization and profit sharin…

8-K · 2026-06-11 · 0001549595-26-000034

Company description from the cited filing.

In the news

Seeking Alpha

Financials

FY 2025 · USD
Revenue83,980,000USD · FY 2025
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

Net income-264,457,000USD · FY 2025
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

Operating income-285,666,000USD · FY 2025
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

Diluted EPS-3.05USD per share · FY 2025
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2026Q3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD1,195,298,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

522,472,000
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2025-08-31

513,600,000
Source

10-Q · 2024-10-11 · 0001549595-24-000131

As of 2024-08-31

535,540,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

591,555,000
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2025-05-31

511,031,000
Source

10-Q · 2024-07-11 · 0001549595-24-000098

As of 2024-05-31

636,130,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

615,043,000
Source

10-Q · 2025-04-08 · 0001549595-25-000055

As of 2025-02-28

688,135,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

669,343,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

355,598,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

416,759,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Property, Plant and Equipment, NetUSD19,407,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

20,498,000
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2025-08-31

17,069,000
Source

10-Q · 2024-10-11 · 0001549595-24-000131

As of 2024-08-31

20,007,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

18,773,000
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2025-05-31

18,557,000
Source

10-Q · 2024-07-11 · 0001549595-24-000098

As of 2024-05-31

21,697,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

18,449,000
Source

10-Q · 2025-04-08 · 0001549595-25-000055

As of 2025-02-28

22,490,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

17,757,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

16,808,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

17,163,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD720,242,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

78,438,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2025-08-31

99,044,000
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2024-08-31

67,685,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

84,260,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2025-05-31

116,790,000
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2024-05-31

71,195,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

75,916,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2025-02-28

246,960,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

109,997,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

54,627,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

64,474,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Assets, CurrentUSD1,103,692,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

440,603,000
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2025-08-31

456,043,000
Source

10-Q · 2024-10-11 · 0001549595-24-000131

As of 2024-08-31

456,481,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

515,330,000
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2025-05-31

450,217,000
Source

10-Q · 2024-07-11 · 0001549595-24-000098

As of 2024-05-31

554,394,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

563,703,000
Source

10-Q · 2025-04-08 · 0001549595-25-000055

As of 2025-02-28

606,819,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

619,387,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

295,503,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

318,449,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Prepaid Expense and Other Assets, CurrentUSD35,437,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

11,774,000
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2025-08-31

7,991,000
Source

10-Q · 2024-10-11 · 0001549595-24-000131

As of 2024-08-31

12,952,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

10,549,000
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2025-05-31

7,078,000
Source

10-Q · 2024-07-11 · 0001549595-24-000098

As of 2024-05-31

13,662,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

14,023,000
Source

10-Q · 2025-04-08 · 0001549595-25-000055

As of 2025-02-28

13,878,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

9,804,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

7,595,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

9,308,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Operating Lease, Right-of-Use AssetUSD48,631,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

53,028,000
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2025-08-31

27,083,000
Source

10-Q · 2024-10-11 · 0001549595-24-000131

As of 2024-08-31

50,107,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

50,214,000
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2025-05-31

28,835,000
Source

10-Q · 2024-07-11 · 0001549595-24-000098

As of 2024-05-31

51,657,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

26,361,000
Source

10-Q · 2025-04-08 · 0001549595-25-000055

As of 2025-02-28

50,517,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

28,139,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

31,142,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

12,345,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Other Assets, NoncurrentUSD7,954,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

7,375,000
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2025-08-31

3,032,000
Source

10-Q · 2024-10-11 · 0001549595-24-000131

As of 2024-08-31

7,977,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

6,337,000
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2025-05-31

3,141,000
Source

10-Q · 2024-07-11 · 0001549595-24-000098

As of 2024-05-31

7,414,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

5,629,000
Source

10-Q · 2025-04-08 · 0001549595-25-000055

As of 2025-02-28

7,341,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

3,159,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

3,823,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

4,022,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

LIABILITIES AND EQUITY
LiabilitiesUSD226,987,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

150,220,000
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2025-08-31

136,744,000
Source

10-Q · 2024-10-11 · 0001549595-24-000131

As of 2024-08-31

132,913,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

143,952,000
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2025-05-31

140,338,000
Source

10-Q · 2024-07-11 · 0001549595-24-000098

As of 2024-05-31

155,237,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

134,126,000
Source

10-Q · 2025-04-08 · 0001549595-25-000055

As of 2025-02-28

149,388,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

142,350,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

155,105,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

113,063,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Stockholders’ equity:
Preferred Stock, Value, IssuedUSD0
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

0
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2025-08-31

0
Source

10-Q · 2024-10-11 · 0001549595-24-000131

As of 2024-08-31

0
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

0
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2025-05-31

0
Source

10-Q · 2024-07-11 · 0001549595-24-000098

As of 2024-05-31

0
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

0
Source

10-Q · 2025-04-08 · 0001549595-25-000055

As of 2025-02-28

0
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

0
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

0
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

0
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Common Stock, Value, IssuedUSD109,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

77,000
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2025-08-31

67,000
Source

10-Q · 2024-10-11 · 0001549595-24-000131

As of 2024-08-31

104,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

76,000
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2025-05-31

64,000
Source

10-Q · 2024-07-11 · 0001549595-24-000098

As of 2024-05-31

103,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

76,000
Source

10-Q · 2025-04-08 · 0001549595-25-000055

As of 2025-02-28

102,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

76,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

49,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

47,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Retained Earnings (Accumulated Deficit)USD-630,128,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

-925,005,000
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2025-08-31

-680,220,000
Source

10-Q · 2024-10-11 · 0001549595-24-000131

As of 2024-08-31

-1,179,935,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

-838,584,000
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2025-05-31

-631,264,000
Source

10-Q · 2024-07-11 · 0001549595-24-000098

As of 2024-05-31

-1,090,400,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

-795,120,000
Source

10-Q · 2025-04-08 · 0001549595-25-000055

As of 2025-02-28

-1,003,226,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

-738,769,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

-545,200,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

-401,252,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD-210,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

119,000
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2025-08-31

344,000
Source

10-Q · 2024-10-11 · 0001549595-24-000131

As of 2024-08-31

-145,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

-20,000
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2025-05-31

-135,000
Source

10-Q · 2024-07-11 · 0001549595-24-000098

As of 2024-05-31

56,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

226,000
Source

10-Q · 2025-04-08 · 0001549595-25-000055

As of 2025-02-28

105,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

150,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

-655,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

-4,319,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Stockholders' Equity Attributable to ParentUSD968,311,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

372,252,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2025-08-31

376,856,000
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2024-08-31

402,627,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

447,603,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2025-05-31

370,693,000
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2024-05-31

480,893,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

480,917,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2025-02-28

538,747,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

526,993,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

200,493,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

303,696,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Additional Paid in Capital, Common StockUSD1,598,540,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

1,297,061,000
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2025-08-31

1,056,665,000
Source

10-Q · 2024-10-11 · 0001549595-24-000131

As of 2024-08-31

1,582,603,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

1,286,131,000
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2025-05-31

1,002,028,000
Source

10-Q · 2024-07-11 · 0001549595-24-000098

As of 2024-05-31

1,571,134,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

1,275,735,000
Source

10-Q · 2025-04-08 · 0001549595-25-000055

As of 2025-02-28

1,541,766,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

1,265,536,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

746,299,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

709,220,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Liabilities and EquityUSD1,195,298,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

522,472,000
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2025-08-31

513,600,000
Source

10-Q · 2024-10-11 · 0001549595-24-000131

As of 2024-08-31

535,540,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

591,555,000
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2025-05-31

511,031,000
Source

10-Q · 2024-07-11 · 0001549595-24-000098

As of 2024-05-31

636,130,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

615,043,000
Source

10-Q · 2025-04-08 · 0001549595-25-000055

As of 2025-02-28

688,135,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

669,343,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

355,598,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

416,759,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Current liabilities:
Liabilities, CurrentUSD130,742,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

82,350,000
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2025-08-31

86,296,000
Source

10-Q · 2024-10-11 · 0001549595-24-000131

As of 2024-08-31

72,020,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

75,614,000
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2025-05-31

80,779,000
Source

10-Q · 2024-07-11 · 0001549595-24-000098

As of 2024-05-31

92,199,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

89,988,000
Source

10-Q · 2025-04-08 · 0001549595-25-000055

As of 2025-02-28

86,471,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

95,854,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

86,958,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

70,655,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Operating Lease, Liability, CurrentUSD3,241,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

3,791,000
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2025-08-31

6,553,000
Source

10-Q · 2024-10-11 · 0001549595-24-000131

As of 2024-08-31

3,221,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

5,235,000
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2025-05-31

7,934,000
Source

10-Q · 2024-07-11 · 0001549595-24-000098

As of 2024-05-31

3,202,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

6,639,000
Source

10-Q · 2025-04-08 · 0001549595-25-000055

As of 2025-02-28

2,824,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

8,014,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

7,489,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

5,530,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Accounts Payable, CurrentUSD32,984,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

8,609,000
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2025-08-31

3,918,000
Source

10-Q · 2024-10-11 · 0001549595-24-000131

As of 2024-08-31

12,208,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

5,954,000
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2025-05-31

2,813,000
Source

10-Q · 2024-07-11 · 0001549595-24-000098

As of 2024-05-31

10,293,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

8,397,000
Source

10-Q · 2025-04-08 · 0001549595-25-000055

As of 2025-02-28

11,215,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

11,482,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

6,401,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

5,064,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Operating Lease, Liability, NoncurrentUSD62,091,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

52,695,000
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2025-08-31

20,590,000
Source

10-Q · 2024-10-11 · 0001549595-24-000131

As of 2024-08-31

54,922,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

46,696,000
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2025-05-31

20,885,000
Source

10-Q · 2024-07-11 · 0001549595-24-000098

As of 2024-05-31

55,453,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

19,984,000
Source

10-Q · 2025-04-08 · 0001549595-25-000055

As of 2025-02-28

52,906,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

20,289,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

23,125,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

6,434,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Additional Financial Items
Cash, Cash Equivalents, and Short-term InvestmentsUSD1,100,000,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

428,800,000
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2025-08-31

448,100,000
Source

10-Q · 2024-10-11 · 0001549595-24-000131

As of 2024-08-31

443,500,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

485,800,000
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2025-05-31

443,100,000
Source

10-Q · 2024-07-11 · 0001549595-24-000098

As of 2024-05-31

540,700,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

549,700,000
Source

10-Q · 2025-04-08 · 0001549595-25-000055

As of 2025-02-28

592,900,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

609,600,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

287,900,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

309,100,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Short-term InvestmentsUSD———————————244,667,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Accounts Receivable, after Allowance for Credit Loss, Current—
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

————
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2025-05-31

———————

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2026Q3 2025Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization———————
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

—
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

—
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

—
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

—
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

—
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Share-based Payment Arrangement, Noncash ExpenseUSD——————9,404,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

8,722,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

37,965,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

33,929,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

33,673,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

28,131,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD—————————0
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

0
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

-6,000,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Increase (Decrease) in Accounts PayableUSD——————-461,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

-3,209,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

-630,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

5,209,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

1,614,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

85,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Net Cash Provided by (Used in) Operating ActivitiesUSD——————-71,914,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

-61,087,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

-249,465,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

-172,584,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

-81,365,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

-159,807,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD——————-123,826,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

25,533,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

147,853,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

-257,713,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

68,301,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

27,198,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Payments to Acquire Property, Plant, and EquipmentUSD——————1,045,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

3,485,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

14,002,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

9,273,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

8,401,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

12,244,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD——————19,975,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

1,473,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

238,642,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

485,667,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

3,217,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

117,192,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————-175,765,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

-34,081,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

137,030,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

55,370,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

-9,847,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

-15,417,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Additional Financial Items
Cash, Cash Equivalents, and Short-term InvestmentsUSD——1,100,000,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

428,800,000
Source

10-Q · 2025-10-09 · 0001549595-25-000113

As of 2025-08-31

443,500,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

485,800,000
Source

10-Q · 2025-07-09 · 0001549595-25-000095

As of 2025-05-31

540,700,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

549,700,000
Source

10-Q · 2025-04-08 · 0001549595-25-000055

As of 2025-02-28

592,900,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

As of 2025-11-30

609,600,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

As of 2024-11-30

287,900,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

As of 2023-11-30

309,100,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

As of 2022-11-30

Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD——————-160,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

0
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

-89,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

-31,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

-556,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

-9,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

General and Administrative ExpenseUSD——34,353,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

13,159,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

15,594,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

14,282,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

14,610,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

11,654,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

52,743,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

45,944,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

42,902,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

37,997,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Income Tax Expense (Benefit)USD——13,606,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

0
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

-271,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

760,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

0
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

0
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

760,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

270,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

—0
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment LossUSD——0
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

0
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

0
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

0
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

0
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

0
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

0
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

———
Net Income (Loss) Attributable to ParentUSD——549,807,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

-86,421,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

-89,535,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

-43,464,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

-87,174,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

-56,351,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

-264,457,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

-193,569,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

-143,948,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

-180,360,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Operating ExpensesUSD——113,613,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

99,279,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

103,247,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

92,378,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

98,747,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

81,317,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

369,646,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

267,576,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

232,050,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

222,494,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Operating Lease, ExpenseUSD——2,600,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

3,900,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

2,600,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

3,700,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

2,600,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

2,200,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

13,300,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

9,000,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

6,800,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

5,900,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Payments to Acquire InvestmentsUSD———————————239,366,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Proceeds from Issuance of Common StockUSD——————18,004,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

0
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

0
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

289,763,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

0
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

19,400,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Proceeds from Stock Options ExercisedUSD——————375,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

221,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

———1,078,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents———
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2026-08-31

—
Source

10-Q · 2026-10-13 · 0001549595-26-000049

As of 2025-08-31

—
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2026-05-31

—
Source

10-Q · 2026-07-09 · 0001549595-26-000040

As of 2025-05-31

—
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2026-02-28

—
Source

10-Q · 2026-04-08 · 0001549595-26-000025

As of 2025-02-28

————

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2026Q3 2025Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Total RevenueUSD——673,064,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

7,894,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

9,043,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

44,056,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

6,252,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

18,453,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

83,980,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

54,549,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

76,987,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

38,627,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Operating Income (Loss)USD——559,451,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

-91,385,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

-94,204,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

-48,322,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

-92,495,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

-62,864,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

-285,666,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

-213,027,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

-155,063,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

-183,867,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD——563,413,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

-86,421,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

-89,806,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

-42,704,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

—-56,351,000
Source

10-Q · 2025-04-08 · 0001549595-25-000055

2024-12-01 to 2025-02-28

-263,697,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

-193,299,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

-143,948,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

-180,360,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Income Tax Expense (Benefit)USD——13,606,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

0
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

-271,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

760,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

0
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

0
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

760,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

270,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

—0
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Net Income (Loss) Attributable to ParentUSD——549,807,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

-86,421,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

-89,535,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

-43,464,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

-87,174,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

-56,351,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

-264,457,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

-193,569,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

-143,948,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

-180,360,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Earnings Per Share, BasicUSD per share——4.93
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

-1.03
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

-0.81
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

-0.52
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

-0.79
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

-0.67
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

-3.05
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

-2.88
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

-2.65
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

-3.71
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Earnings Per Share, DilutedUSD per share——4.73
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

-1.03
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

-0.81
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

-0.52
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

-0.79
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

-0.67
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

-3.05
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

-2.88
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

-2.65
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

-3.71
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Weighted Average Number of Shares Outstanding, Basicshares——111,563,067
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

84,159,336
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

111,084,423
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

83,882,477
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

110,071,668
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

83,560,795
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

86,666,907
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

67,120,266
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

54,337,901
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

48,607,990
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Weighted Average Number of Shares Outstanding, Dilutedshares——116,152,771
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

84,159,336
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

111,084,423
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

83,882,477
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

110,071,668
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

83,560,795
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

86,666,907
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

67,120,266
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

54,337,901
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

48,607,990
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Additional Financial Items
Common Stock, Dividends, Per Share, DeclaredUSD per share——————0
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

0
Source

10-Q · 2025-04-08 · 0001549595-25-000055

2024-12-01 to 2025-02-28

0
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

0
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

——
Current Income Tax Expense (Benefit)USD——————————0
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

0
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Depreciation, Depletion and Amortization, NonproductionUSD——————2,196,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

2,350,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

8,740,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

9,318,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

7,533,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

5,349,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

General and Administrative ExpenseUSD——34,353,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

13,159,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

15,594,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

14,282,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

14,610,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

11,654,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

52,743,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

45,944,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

42,902,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

37,997,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD————————-263,697,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

-193,299,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

-143,948,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

-180,360,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Interest and Other IncomeUSD——3,962,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

4,964,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

4,398,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

5,618,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

5,321,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

6,513,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

21,969,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

19,728,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

11,115,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

3,507,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment LossUSD——0
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

0
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

0
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

0
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

0
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

0
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

0
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

———
Operating ExpensesUSD——113,613,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

99,279,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

103,247,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

92,378,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

98,747,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

81,317,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

369,646,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

267,576,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

232,050,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

222,494,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Operating Lease, ExpenseUSD——2,600,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

3,900,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

2,600,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

3,700,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

2,600,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

2,200,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

13,300,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

9,000,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

6,800,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

5,900,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Research and Development ExpenseUSD——79,260,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2026-06-01 to 2026-08-31

86,120,000
Source

10-Q · 2026-10-13 · 0001549595-26-000049

2025-06-01 to 2025-08-31

87,653,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2026-03-01 to 2026-05-31

78,096,000
Source

10-Q · 2026-07-09 · 0001549595-26-000040

2025-03-01 to 2025-05-31

84,137,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2025-12-01 to 2026-02-28

69,663,000
Source

10-Q · 2026-04-08 · 0001549595-26-000025

2024-12-01 to 2025-02-28

316,903,000
Source

10-K · 2026-01-28 · 0001549595-26-000016

2024-12-01 to 2025-11-30

221,632,000
Source

10-K · 2025-01-28 · 0001549595-25-000016

2023-12-01 to 2024-11-30

189,148,000
Source

10-K · 2024-02-15 · 0001549595-24-000025

2022-12-01 to 2023-11-30

184,497,000
Source

10-K · 2023-02-09 · 0001549595-23-000021

2021-12-01 to 2022-11-30

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

ex991_nurixpressrelease202.htm · 8-K · 2026-06-11

EX-99.1 2 ex991_nurixpressrelease202.htm EX-99.1 Document Exhibit 99.1 [Nurix Logo] Nurix Therapeutics to Report Updated Phase 1a/b Results for BTK Degrader Bexobrutideg, Highlighting Durable Responses in Relapsed/Refractory CLL/SLL and Promising Activity in Earlier Lines of Therapy High objective response rate of 92.9% in second line patients who have progressed on a BTK inhibitor and have not received BCL2 inhibitor treatment Updated Phase 1a data further supports a median progression…

8-K · 2026-06-11 · 0001549595-26-000034

Read attachment ↗
ex991_nurixpressrelease202.htm · 8-K · 2026-06-08

EX-99.1 2 ex991_nurixpressrelease202.htm EX-99.1 Document Exhibit 99.1 [NURIX LOGO] Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology Strategic collaboration combines Nurix’s leadership in targeted protein degradation with Roche’s portfolio of B-cell targeted therapies and global clinical and commercialization footprint Robust clinical dev…

8-K · 2026-06-08 · 0001549595-26-000030

Read attachment ↗
ex992_nurixpresentation2.htm · 8-K · 2026-06-08

EX-99.2 3 ex992_nurixpresentation2.htm EX-99.2 ex992_nurixpresentation2 Unlocking the Full Potential of Bexobrutideg A Global Collaboration Between Nurix and Roche June 8, 2026 Exhibit 99.2 Forward Looking Statements 2 This presentation contains statements that relate to future events and expectations and as such constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When or if used in this presentation, the words “anticipate,” “be…

8-K · 2026-06-08 · 0001549595-26-000030

Read attachment ↗
ex992_260112xjpmpressrelea.htm · 8-K · 2026-01-12

EX-99.2 3 ex992_260112xjpmpressrelea.htm EX-99.2 Document [Nurix Logo] Exhibit 99.2 Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader-Based Medicines in Cancer and Autoimmune Diseases Execute a pivotal program for potential best-in-class BTK degrader, bexobrutideg, including Phase 2 and confirmatory Phase 3 studies to support global registration in relapsed/refractory chronic lymphocytic leukemia (r/r CLL) Expand bexobrut…

8-K · 2026-01-12 · 0001549595-26-000003

Read attachment ↗
ex991_251206xashxcllxdatap.htm · 8-K · 2025-12-09

EX-99.1 2 ex991_251206xashxcllxdatap.htm EX-99.1 Document [Nurix Logo] Exhibit 99.1 Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition Objective response rate (ORR) of 83% including two complete responses in CLL patients in Phase 1a study with median progression free …

8-K · 2025-12-09 · 0001549595-25-000121

Read attachment ↗
ex992_251208bexdegwmclinic.htm · 8-K · 2025-12-09

EX-99.2 3 ex992_251208bexdegwmclinic.htm EX-99.2 Document [Nurix logo] Exhibit 99.2 Nurix Therapeutics Presents New Data from the Phase 1 Trial of Bexobrutideg (NX-5948) in Waldenström Macroglobulinemia at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition Objective response rate (ORR) of 75.0% including three very good partial responses (VGPR) in heavily pre-treated Waldenström macroglobulinemia patients With a median follow up of 8.1 months, median duration of…

8-K · 2025-12-09 · 0001549595-25-000121

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.